|
Status |
Public on Nov 06, 2017 |
Title |
231_1a3_nt_rep1 [methylation] |
Sample type |
genomic |
|
|
Source name |
MDA-MB-231 1a3 NT
|
Organism |
Homo sapiens |
Characteristics |
cell line: MDA-MB-231 vector: MSCV ALDH1A3 overexpression atra: 0 nM decitabine: 0 uM replicate: 1
|
Treatment protocol |
atRA and decitabine as inidcated.
|
Growth protocol |
MDA-MB-231 and MDA-MB-468 cells grown in DMEM with 10% FBS, 1x antibiotic-antimycotic, 0.25 ug/mL puromycin.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA extracted with the PureLink DNA kit (Invitrogen)
|
Label |
cy3, cy5
|
Label protocol |
as described in Illumina protocol
|
|
|
Hybridization protocol |
as described in Illumina protocol
|
Scan protocol |
as described in Illumina protocol
|
Description |
1A3 NT 1
|
Data processing |
as described in Illumina protocol
|
|
|
Submission date |
Sep 04, 2017 |
Last update date |
Jan 23, 2018 |
Contact name |
Paola Marcato |
Organization name |
Dalhousie University
|
Department |
Pathology
|
Street address |
PO Box 15000
|
City |
Halifax |
State/province |
Nova Scotia |
ZIP/Postal code |
B3H 4R2 |
Country |
Canada |
|
|
Platform ID |
GPL13534 |
Series (2) |
GSE103425 |
DNA methylation profiling of MDA-MB-231 and MDA-MB-468 after ALDH1A3 manipulation, all-trans retinoic acid treatment, decitabine treatment |
GSE103427 |
Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression |
|